Bank of Montreal’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-856
Closed -$8K 5078
2021
Q1
$8K Sell
856
-3,809
-82% -$52.5K ﹤0.01% 4484
2020
Q4
$27K Buy
4,665
+3,270
+234% +$9.89K ﹤0.01% 4290
2020
Q3
$4K Sell
1,395
-989
-41% -$3.67K ﹤0.01% 4541
2020
Q2
$17K Buy
2,384
+2,164
+984% +$14.6K ﹤0.01% 3930
2020
Q1
$1K Sell
220
-3,164
-93% -$26.6K ﹤0.01% 4002
2019
Q4
$30K Buy
3,384
+1,201
+55% +$10K ﹤0.01% 4089
2019
Q3
$19K Buy
2,183
+91
+4% +$919 ﹤0.01% 4135
2019
Q2
$23K Buy
2,092
+2,091
+209,100% +$23.9K ﹤0.01% 4107
2019
Q1
$0 Buy
+1
New +$13 ﹤0.01% 4831

Other funds holding GRTS

Bank of Montreal's GRTS Position: Q2 2021 in Review

Bank of Montreal sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2021, closing a stake of 856 shares — an estimated $8K sold.

Bank of Montreal first reported a position in GRTS in Q1 2019 and held it in 9 quarters. The position peaked at $30K in Q4 2019. 102 funds tracked by Wall St. Rank hold GRTS as of Q2 2021.

  • Bank of Montreal reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 856 Gritstone bio, Inc. Common Stock shares in Q2 2021, an estimated $8K.
  • Bank of Montreal first reported a position in Gritstone bio, Inc. Common Stock in Q1 2019 and held it in 9 quarters.
  • Bank of Montreal's Gritstone bio, Inc. Common Stock position peaked at $30K in Q4 2019.
  • 102 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.